NCT00296777View on ClinicalTrials.gov

Treatment of Depression Following Multiple Brain Tests

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

May 31, 2007

Study Completion Date

December 31, 2007

Conditions
Major DepressionDysthymia
Interventions
DRUG

Escitalopram

8 weeks: up to 40 mg/day

DRUG

Bupropion

8 weeks: up to 450 mg/day (for patients without history of seizures or risk for developing seizures.

DRUG

Imipramine

"8 weeks: up to 300mg/day~\*if patient does not have contraindication."

Trial Locations (1)

10032

Depression Evaluation Service - New York State Psychiatric Institute, New York

All Listed Sponsors
lead

New York State Psychiatric Institute

OTHER

NCT00296777 - Treatment of Depression Following Multiple Brain Tests | Biotech Hunter | Biotech Hunter